Gold price flirts with $5,000 again as a soft dollar and Fed bets keep bulls in play

Gold price flirts with $5,000 again as a soft dollar and Fed bets keep bulls in play

New York, January 23, 2026, 06:11 (EST) — Premarket

Gold climbed to a fresh record on Friday, pushing close to $5,000 an ounce before pulling back slightly in early trading. Spot gold slipped 0.4% to $4,917.37 per ounce by 0851 GMT, after hitting a session high of $4,967.03. U.S. gold futures for February rose 0.2% to $4,921.70. “Faith in the U.S. and its assets have been shaken, maybe permanently,” said Kyle Rodda, senior market analyst at Capital.com. (Reuters)

Gold’s surge at the start of 2026 is shaking up investor calculations, prompting a fresh look at risk and the dollar’s influence. On Thursday, bullion climbed above $4,900 for the first time. Traders pointed to a softer dollar index — which tracks the greenback against key currencies — alongside steady bets on Federal Reserve rate cuts later this year. “Those factors are part and parcel of the macro ‘de-dollarisation’ trend,” said Peter Grant, vice president and senior metals strategist at Zaner Metals. Silver and platinum also hit new highs in the rally. (Reuters)

U.S. data left the rates story largely intact. The Personal Consumption Expenditures (PCE) price index — the Fed’s go-to inflation measure — climbed 0.2% in November and was up 2.8% year-over-year. Consumer spending also increased by 0.5% in both October and November, according to the Commerce Department’s Bureau of Economic Analysis, which released the numbers after a 43-day government shutdown. (Reuters)

Goldman Sachs raised its gold price forecast for the end of 2026 to $5,400 an ounce, up from $4,900. The bank highlighted growing demand from private-sector buyers and emerging market central banks diversifying into bullion. “We assume private sector diversification buyers … don’t liquidate their gold holdings in 2026,” it said, though it cautioned that a sudden drop in macro-policy risks could prompt hedge unwinds, putting downward pressure on prices. (Reuters)

Physical markets are starting to feel the pressure from the rally. In India, premiums surged to $112 an ounce above official domestic prices this week — the highest level since May 2014 — as investors rushed to buy ahead of the Feb. 1 budget, which some anticipate will include an import duty hike. “With a duty hike expected in the budget, investors jumped in and bought aggressively,” said Chanda Venkatesh, managing director of Hyderabad-based bullion merchant CapsGold. (Reuters)

U.S. markets are eyeing the Fed’s upcoming two-day meeting on Jan. 27–28. The policy decision and Chair’s press briefing will come on Jan. 28. (Federal Reserve)

The rally isn’t guaranteed to hold. A dollar bounce, rising yields, or hints the Fed won’t rush to ease might push quick traders to exit crowded longs, especially as gold edges closer to the $5,000 mark.

Traders are focused on two key points: can bullion stay above the previous breakout level around $4,900, and will the Fed’s message on Jan. 28 confirm or challenge the market’s expectations for rate cuts this year.

Stock Market Today

  • Oric Pharmaceuticals Shares Poised for 74% Upside as Biotech Innovation Draws Investor Attention
    January 23, 2026, 8:13 AM EST. Oric Pharmaceuticals (NASDAQ: ORIC) is gaining investor interest with a potential 74% upside from its current $12.05 share price, backed by partnerships with Pfizer, Bayer, and Johnson & Johnson. The clinical-stage biotech focuses on therapies addressing cancer treatment resistance, advancing candidates like ORIC-114 and ORIC-944 through early-stage trials. Despite a $1.17 billion market cap, Oric reports a negative EPS of -1.71 and free cash flow of -$70.7 million, reflecting typical high-risk biotech dynamics. With no dividends and a neutral RSI, stock momentum shows cautious optimism. Analysts rate ORIC with 14 buys and project a $21 average target price, suggesting substantial growth for investors able to tolerate the sector's inherent uncertainties.
UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move
Previous Story

UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move

Intel stock sinks in premarket after weak outlook; AI data-center supply crunch bites
Next Story

Intel stock sinks in premarket after weak outlook; AI data-center supply crunch bites

Go toTop